BetterLife Pharma Inc.

DB:NPAU Stock Report

Market Cap: €10.5m

BetterLife Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:NPAU Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Feb 25Buy€7,411Stephen SanghaIndividual100,000€0.074
20 Jan 25Buy€10,396Stephen SanghaIndividual129,000€0.081
14 Jan 25Buy€15,561Stephen SanghaIndividual200,000€0.078
13 Jan 25Buy€8,664Stephen SanghaIndividual110,756€0.078
10 Jan 25Buy€1,880Stephen SanghaIndividual24,152€0.078
18 Dec 24Buy€909Stephen SanghaIndividual13,000€0.07
18 Dec 24Buy€2,588Stephen SanghaIndividual37,000€0.07
17 Dec 24Buy€3,680Stephen SanghaIndividual52,700€0.07
17 Dec 24Buy€3,492Stephen SanghaIndividual50,000€0.07
13 Dec 24Buy€1,399Stephen SanghaIndividual19,000€0.074
12 Dec 24Buy€1,932Stephen SanghaIndividual25,000€0.077
06 Dec 24Buy€6,472Stephen SanghaIndividual87,900€0.074
08 Aug 24Buy€9,276Stephen SanghaIndividual107,000€0.087
14 Jun 24Buy€34,003Ahmad DoroudianIndividual500,000€0.068
28 Feb 24Buy€14,447Stephen SanghaIndividual250,000€0.058
13 Feb 24Buy€4,056Stephen SanghaIndividual65,500€0.062

Insider Trading Volume

Insider Buying: NPAU insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NPAU?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders36,883,82328.5%
General Public92,689,56571.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 8 shareholders own 28.47% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.9%
Stephen Sangha
20,539,756€1.7m9.89%no data
10.2%
Ahmad Doroudian
13,263,313€1.1m0%no data
1.07%
Hooshmand Sheshbaradaran
1,386,281€112.3k0%no data
0.76%
Hamid Doroudian
987,148€80.0k0%no data
0.49%
Moira Ong
637,825€51.7k0%no data
0.028%
Wolfgang Renz
36,500€3.0k0%no data
0.023%
Robert Metcalfe
30,000€2.4k0%no data
0.0023%
Ralph Pullen
3,000€243.60%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/11 01:50
End of Day Share Price 2025/02/11 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BetterLife Pharma Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.